Patents by Inventor Hazel Hunt

Hazel Hunt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FATTY LIVER DISEASE TREATMENT USING GLUCOCORTICOID AND MINERALOCORTICOID RECEPTOR ANTAGONISTS
    Publication number: 20160106749
    Abstract: The present invention provides treatment of fatty liver disease using a class of pyrimidinedione cyclohexyl compounds.
    Type: Application
    Filed: October 14, 2015
    Publication date: April 21, 2016
    Inventors: Joseph K. Belanoff, Hazel Hunt, Onno C. Meijer, José van den Heuvel
  • Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
    Patent number: 9273047
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: March 1, 2016
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters
  • OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20150148341
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: November 21, 2014
    Publication date: May 28, 2015
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20150080389
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: September 16, 2014
    Publication date: March 19, 2015
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters
  • Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
    Patent number: 8859774
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: October 14, 2014
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters
  • Adenine inhibitors of HSP90
    Patent number: 8669248
    Abstract: In general, the present invention relates to small molecule inhibitors of the heat shock protein 90 family of chaperone proteins. The invention also features pharmaceutical compositions and kits that include the compounds and compositions of the invention. The invention further relates to the medical use of these compounds and compositions for the treatment of neurodegenerative diseases.
    Type: Grant
    Filed: September 30, 2011
    Date of Patent: March 11, 2014
    Inventors: John Montana, Janusz Kulagowski, Hazel Hunt, Yukari Perrella
  • Heteroaryl-Ketone Fused Azadecalin Glucocorticoid Receptor Modulators
    Publication number: 20140038926
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: May 24, 2013
    Publication date: February 6, 2014
    Applicant: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters
  • Pyridyl-amine fused azadecalin modulators
    Patent number: 8598154
    Abstract: The present invention provides a novel class of pyridyl-amine fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: December 3, 2013
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Robin Clark, Tony Johnson, Hazel Hunt, Ian McDonald
  • Azadecalin glucocorticoid receptor modulators
    Patent number: 8324203
    Abstract: The present invention provides a novel class of azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: January 21, 2010
    Date of Patent: December 4, 2012
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Robin D. Clark, Nicholas C. Ray, Paul Blaney, Christopher Hurley, Hazel Hunt, David Clark, Karen Williams
  • PYRIDYL-AMINE FUSED AZADECALIN MODULATORS
    Publication number: 20120220565
    Abstract: The present invention provides a novel class of pyridyl-amine fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: August 26, 2011
    Publication date: August 30, 2012
    Applicant: Corcept Therapeutics, Inc.
    Inventors: Robin Clark, Tony Johnson, Hazel Hunt, Ian McDonald
  • AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20100120759
    Abstract: The present invention provides a novel class of azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: January 21, 2010
    Publication date: May 13, 2010
    Applicant: Corcept Therapeutics, Inc.
    Inventors: Robin D. CLARK, Nicholas C. RAY, Paul BLANEY, Christopher HURLEY, Hazel HUNT, David CLARK, Karen WILLIAMS
  • Azadecalin Glucocorticoid receptor modulators
    Patent number: 7678813
    Abstract: The present invention provides a novel class of azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: January 10, 2005
    Date of Patent: March 16, 2010
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Robin D. Clark, Nicholas C. Ray, Paul Blaney, Christopher Hurley, Hazel Hunt, David Clark, Karen Williams
  • Substituted bis aryl and heteroaryl compounds as selective 5HTantagonists
    Patent number: 7625889
    Abstract: The present invention relates to a series of substituted bis aryl and heteroaryl compounds of formula (I): Wherein X, Y, Z, A, B, D, Ar, R1 and R2 are as defined herein. The compounds of this invention are selective 5HT2A antagonists, and are therefore, useful in treating a variety of diseases including but not limited to a wide variety of sleep disorders as disclosed and claimed herein.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: December 1, 2009
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Paul Robert Eastwood, Hazel Hunt, David Mark Fink, Helen Katherine Smith, Richard Simon Todd
  • SUBSTITUTED BIS ARYL AND HETEROARYL COMPOUNDS AS SELECTIVE 5HT2A ANTAGONISTS
    Publication number: 20070265309
    Abstract: The present invention relates to a series of substituted bis aryl and heteroaryl compounds of formula (I): Wherein X, Y, Z, A, B, D, Ar, R1 and R2 are as defined herein. The compounds of this invention are selective 5HT2A antagonists, and are therefore, useful in treating a variety of diseases including but not limited to a wide variety of sleep disorders as disclosed and claimed herein.
    Type: Application
    Filed: July 25, 2007
    Publication date: November 15, 2007
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Paul EASTWOOD, Hazel HUNT, David FINK, Helen SMITH, Richard TODD
  • Azadecalin Glucocorticoid Receptor Modulators
    Publication number: 20070203179
    Abstract: The present invention provides a novel class of azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: January 10, 2005
    Publication date: August 30, 2007
    Applicant: Corcept Therapeutics, Inc.
    Inventors: Robin Clark, Nicholas Ray, Paul Blaney, Christopher Hurley, Hazel Hunt, David Clark, Karen Williams